Oak Grove Capital LLC Takeda Pharmaceutical CO LTD Call Options Transaction History
Oak Grove Capital LLC
- $601 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
357Shares Held
66.3MCall Options Held
3.35MPut Options Held
198K-
Capital Research Global Investors Los Angeles, CA13.2MShares$187 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$79.5 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$75.5 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.16MShares$44.8 Million0.08% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.04MShares$43.1 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...